IOVANCE BIOTHERAPEUTICS INC's ticker is IOVA and the CUSIP is 462260100. A total of 228 filers reported holding IOVANCE BIOTHERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.35 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $207,334 | -8.8% | 45,568 | +41.1% | 0.00% | – |
| Q2 2023 | $227,336 | +20.0% | 32,292 | +4.2% | 0.00% | -100.0% |
| Q1 2023 | $189,410 | -4.4% | 31,000 | 0.0% | 0.00% | +33.3% |
| Q4 2022 | $198,090 | -54.0% | 31,000 | -31.1% | 0.00% | -40.0% |
| Q3 2022 | $431,000 | +62.6% | 45,000 | +87.3% | 0.01% | +66.7% |
| Q2 2022 | $265,000 | -44.7% | 24,032 | -16.5% | 0.00% | -40.0% |
| Q1 2022 | $479,000 | +29.8% | 28,794 | +48.5% | 0.01% | +25.0% |
| Q4 2021 | $369,000 | -20.8% | 19,387 | +2.6% | 0.00% | -33.3% |
| Q3 2021 | $466,000 | -22.3% | 18,892 | -18.1% | 0.01% | -25.0% |
| Q2 2021 | $600,000 | +80.2% | 23,066 | +118.9% | 0.01% | +60.0% |
| Q1 2021 | $333,000 | – | 10,535 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Perceptive Advisors | 12,201,261 | $203,150,000 | 4.07% |
| Paradigm Biocapital Advisors LP | 907,428 | $15,109,000 | 4.00% |
| Avoro Capital Advisors LLC | 9,125,000 | $151,931,000 | 2.77% |
| Logos Global Management LP | 1,000,000 | $16,650,000 | 2.16% |
| Avidity Partners Management LP | 6,043,219 | $100,620,000 | 2.10% |
| Orbimed Advisors | 6,633,006 | $110,440,000 | 1.79% |
| Parametrica Management Ltd | 134,679 | $2,240,000 | 1.66% |
| Boxer Capital, LLC | 1,935,133 | $32,220,000 | 1.66% |
| Fairmount Funds Management LLC | 389,588 | $6,487,000 | 1.53% |
| Long Focus Capital Management, LLC | 705,000 | $11,738,000 | 1.51% |